North America Pacemakers Market to 2027- Regional Analysis and Forecasts By Product Type (Implantable Pacemakers, External Pacemakers) By Technology (Single Chambered, Dual Chambered, and Bi-Ventricular), By End User (Hospitals, Ambulatory Surgical Centers, and Others), and Country
Publication Month: Jun 2019
Report Code: TIPRE00005754 No. of Pages: 137 Category: Medical Device Status: Published
The North America pacemakers market is expected to reach US$ 5,144.2 Mn in 2027 from US$ 2,607.1 Mn in 2018. The market is estimated to grow with a CAGR of 8.0% from 2019-2027.
Key factors that are driving the growth of the market are rising incidence of cardiovascular diseases, significant geriatric population present in the region that is susceptible to the risk of chronic heart diseases and presence of key players in the market and major technological advancements made by the North American players in the market.
Cardiovascular diseases represent a class of multiple diseases related to blood vessels and heart. According to the World Health Organization 2017, approximately 90% of cardiovascular diseases are preventable. The WHO also states that CVD is the leading cause of death in US and worldwide. In 2017, according to the World health organization, the increasing prevalence of cardiovascular diseases is the major cause of death all over the world. Cardiovascular disease is one of the leading causes of morbidity and mortality and is responsible for 30% of worldwide mortality, according to the World Health Organization. Moreover, according to the Centers of Disease Control and Prevention, Coronary heart disease (CHD) is the most common type of heart disease, killing over 370,000 people annually. Furthermore, according to the American Heart Association, in 2016, Coronary Heart Disease was the leading cause (43.2%) of deaths attributable to cardiovascular disease in the US, followed by stroke (16.9%), High Blood Pressure (9.8%), Heart Failure (9.3%), diseases of the arteries (3.0%), and other cardiovascular diseases (17.7%). Thus, such a high prevalence of cardiovascular diseases globally is anticipated to lead the market growth in the coming years.
The pacemakers market, based on product type, is segmented into implantable pacemakers and external pacemakers. In 2018, the implantable pacemakers segment held the largest share of the market, by product type. Moreover, the same segment of pacemakers market is also expected to witness growth in its demand at the fastest CAGR of 8.3% from 2019 to 2027. The spurring adoption of these devices relies majorly on the availability of reimbursement that results in reducing the economic burden on the patients in the developed economies that have a high prevalence of cardiovascular diseases. Moreover, the implantable pacemakers are highly penetrated in the market and thus are adopted as a first preference due to low risk, and other advantages offered by these devices.
Get more information on this report :
NORTH AMERICA PACEMAKERS– MARKET SEGMENTATION
By Product Type
- Implantable Pacemakers
- External Pacemakers
By Technology
By End User
- Hospitals
- Ambulatory Surgical Centres
- Others
By Country
- U.S
- Canada
- Mexico
Companies Mentioned
- Medico S.p.A.
- Vitatron
- Abbott
- Medtronic
- OSCOR
- LivaNova Plc
- Abiomed
- Boston Scientific Corporation
- Biotronik
- Lepu Medical
1. Introduction
1.1 Scope Of The Study
1.2 The Insight Partners Research Report Guidance
2. North America Pacemakers Market – Key Takeaways
3. North America Pacemakers Market – Market Landscape
3.1 Overview
3.2 Market Segmentation
3.2.1 North America Pacemakers Market – By Product Type
3.2.2 North America Pacemakers Market – By Technology
3.2.3 North America Pacemakers Market – By End User
3.2.4 North America Pacemakers Market – By Country
3.3 PEST Analysis
4. North America Pacemakers Market- Key Market Dynamics
4.1 Key Market Drivers
4.1.1 Rising Number of Patients Suffering with Cardiovascular Diseases
4.1.2 Introduction of Novel Pacemakers
4.2 Key Market Restraints
4.2.1 Product Recalls
4.3 Key Market Opportunities
4.3.1 Increasing Patient Compliance
4.4 Future Trends
4.4.1 Continuous Product Developments
4.5 Impact Analysis
5. Pacemakers Market – North America Analysis
5.1 North America Pacemakers Market Revenue Forecasts And Analysis
5.2 Market Positioning
5.3 Performance Of Key Players
6. Pacemakers Market – North America Regulatory Scenario
6.1 north america
6.1.1 US
6.1.2 Canada
6.1.3 Mexico
7. North America Pacemakers Market Analysis – By Product Type
7.1 Overview
7.2 North America Pacemakers Market, By Product Type, 2018 & 2027 (%)
7.3 North America Pacemakers Market Revenue And Forecasts To 2027, By Product Type (US$ Mn)
7.4 Implantable Pacemakers market
7.4.1 Overview
7.4.2 Implantable Pacemakers market Revenue and Forecast to 2027 (US$ Mn)
7.5 External Pacemakers Market
7.5.1 Overview
7.5.2 External Pacemakers Market Revenue and Forecast to 2027 (US$ Mn)
8. North America Pacemakers Market Analysis – By Technology
8.1 Overview
8.2 North America Pacemakers Market, By Technology, 2018 & 2027 (%)
8.3 North America Pacemakers Market Revenue And Forecasts To 2027, By Technology (US$ Mn)
8.4 Single Chambered Market
8.4.1 Overview
8.4.2 North America Single-Chambered Market Revenue and Forecasts to 2027 (US$ Mn)
8.5 Dual Chambered Market
8.5.1 Overview
8.5.2 North America Dual Chambered Market Revenue and Forecasts to 2027 (US$ Mn)
8.6 Bi-Ventricular Market
8.6.1 Overview
8.6.2 North America Bi-Ventricular Market Revenue and Forecasts to 2027 (US$ Mn)
9. North America Pacemakers Market Analysis – By End User
9.1 Overview
9.2 North America Pacemakers Market, By End User, 2018 & 2027 (%)
9.3 North America Pacemakers Market Revenue And Forecasts To 2027, By End User (US$ Mn)
9.4 Hospitals Market
9.4.1 Overview
9.4.2 North America Hospitals Market Revenue and Forecasts to 2027 (US$ Mn)
9.5 Ambulatory Surgical Centres Market
9.5.1 Overview
9.5.2 North America Ambulatory Surgical Centres Market Revenue and Forecasts to 2027 (US$ Mn)
9.6 Others Market
9.6.1 Overview
9.6.2 North America Others Market Revenue and Forecasts to 2027 (US$ Mn)
10. North America Pacemakers market
10.1.1 Overview
10.1.2 North America Pacemakers Market Revenue And Forecasts to 2027 (US$ Mn)
10.1.3 North America Pacemakers Market Revenue And Forecasts to 2027, By Product Type (US$ Mn)
10.1.4 North America Pacemakers Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
10.1.5 North America Pacemakers Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10.1.6 North America Pacemakers Market Revenue and Forecasts to 2027, By Country (%)
10.1.7 US Pacemakers Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.8 US Pacemakers Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.8.1 US Pacemakers Market Revenue And Forecasts to 2027, By Product Type (US$ Mn)
10.1.8.2 US Pacemakers Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
10.1.8.3 US Pacemakers Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10.1.9 Canada Pacemakers Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.10 Canada Pacemakers Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.10.1 Canada Pacemakers Market Revenue And Forecasts to 2027, By Product Type (US$ Mn)
10.1.10.2 Canada Pacemakers Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
10.1.10.3 Canada Pacemakers Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10.1.11 Mexico Pacemakers Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.12 Mexico Pacemakers Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.12.1 Mexico Pacemakers Market Revenue And Forecasts to 2027, By Product Type (US$ Mn)
10.1.12.2 Mexico Pacemakers Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
10.1.12.3 Mexico Pacemakers Market Revenue And Forecasts to 2027, By End User (US$ Mn)
11. Pacemakers Market – Industry Landscape
11.1 Overview
11.2 Comparative Company Analysis
11.3 Growth Strategies Done by the Companies in the Market, (%)
11.4 Organic Developments
11.4.1 Overview
11.5 Inorganic Developments
11.5.1 Overview
12. Pacemakers Market–Key Company Profiles
12.1 MEDICO S.p.A.
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Financial Overview
12.1.4 Product Portfolio
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Vitatron Holding B.V.
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Financial Overview
12.2.4 Product Portfolio
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Abbott
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Financial Information
12.3.4 Product Portfolio
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Medtronic
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Financial Information
12.4.4 Product Portfolio
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 OSCOR Inc
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Financial Information
12.5.4 Product Portfolio
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 LivaNova PLC
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Financial Overview
12.6.4 Product Portfolio
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 LEpu Medical
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Financial Overview
12.7.4 Product Portfolio
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Boston Scientific Corporation
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Financial Overview
12.8.4 Product Portfolio
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 BIOTRONIK
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Financial Overview
12.9.4 Product Portfolio
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Pacetronix
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Financial Overview
12.10.4 Product Portfolio
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary Of Terms
13.3 Methodology
13.3.1 Coverage
13.3.2 Secondary Research
13.3.3 Primary Research
LIST OF TABLES
Table 1. North America Pacemakers Market Revenue And Forecasts To 2027, By Product Type (US$ Mn)
Table 2. North America Pacemakers Market Revenue And Forecasts To 2027, By Technology (US$ Mn)
Table 3. North America Pacemakers Market Revenue And Forecasts To 2027, By End User (US$ Mn)
Table 4. North America Pacemakers market Revenue And Forecasts to 2027, By Product type (US$ Mn)
Table 5. North America Pacemakers market Revenue And Forecasts to 2027, By technology (US$ Mn)
Table 6. North America Pacemakers market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 7. US Pacemakers market Revenue And Forecasts to 2027, By Product Type (US$ Mn)
Table 8. US Pacemakers market Revenue And Forecasts to 2027, By Technology (US$ Mn)
Table 9. US Pacemakers market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 10. Canada Pacemakers market Revenue And Forecasts to 2027, By Product Type (US$ Mn)
Table 11. Canada Pacemakers market Revenue And Forecasts to 2027, By Technology (US$ Mn)
Table 12. Canada Pacemakers market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 13. Mexico Pacemakers market Revenue And Forecasts to 2027, By Product Type (US$ Mn)
Table 14. Mexico Pacemakers market Revenue And Forecasts to 2027, By Technology (US$ Mn)
Table 15. Mexico Pacemakers market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 16. Organic Developments Done By Companies
Table 17. Inorganic developments done by Companies
Table 18. Glossary Of Terms, Pacemakers Market
LIST OF FIGURES
Figure 1. US Pacemakers Market, Revenue (US$ Mn), By Country 2018 & 2027
Figure 2. North America Pacemakers Market By Product Type, Market Share (%), 2018
Figure 3. North America Pacemakers Market By Technology, Market Share (%), 2018
Figure 4. North America Pacemakers Market By End User, Market Share (%), 2018
Figure 5. Pacemakers Market Segmentation
Figure 6. North America PEST Analysis
Figure 7. Pacemakers Market Impact Analysis Of Drivers & Restraints
Figure 8. North America Pacemakers Market – Revenue Forecasts And Analysis – 2018- 2027
Figure 9. North America Pacemakers Market, By Product Type, 2018 & 2027 (%)
Figure 10. Implantable Pacemakers Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 11. External Pacemakers Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 12. North America Pacemakers Market By Technology, 2017 & 2025 (%)
Figure 13. North America Single Chambered Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 14. North America Dual Chambered Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 15. North America Bi-Ventricular Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 16. North America Pacemakers Market By End User, 2018 & 2027 (%)
Figure 17. North America Hospitals Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 18. North America Ambulatory Surgical Centers Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 19. North America Others Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 20. North America Pacemakers market revenue Overview, by Country (2017) (us $ mn)
Figure 21. North America Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 22. North America Pacemakers market Revenue And Forecasts to 2027, By Country (%)
Figure 23. US Pacemakers market Revenue and Forecasts to 2027 (US$ Mn)
Figure 24. Canada Pacemakers market Revenue and Forecasts to 2027 (US$ Mn)
Figure 25. Mexico Pacemakers market Revenue and Forecasts to 2027 (US$ Mn)
Figure 26. Comparative Company Analysis
Figure 27. Growth Strategies Done by the Companies in the Market, (%)
The List of Companies
- Medico S.p.A.
- Vitatron
- Abbott
- Medtronic
- OSCOR
- LivaNova Plc
- Abiomed
- Boston Scientific Corporation
- Biotronik
- Lepu Medical